close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Novartis's Kymriah Flunks In Late-Stage NHL Study
Tickers NVS
Tags News Market News Non Hodgkin Lymphoma
From Benzinga
Investors React Positively To Data From Orphazyme's Neurodegenerative Disease Candidate
Tickers ORPH
Tags Phase 3 Trial Phase 2 Trial Movers
From Benzinga
Why Did AstraZeneca's Alexion Stop Amyotrophic Lateral Sclerosis Trial?
Tickers AZN AZNCF
Tags General Benzinga AZN
From Benzinga
See Why Coherus Stock Is Rising After Toripalimab Combination Trial In Lung Cancer
Tickers CHRS
Tags Market News Long Ideas News
From Benzinga
DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
Tickers BPTS
Tags FDA Health Care Biotech
From Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Tickers LLY
Tags Phase 3 Trial Health Care Biotech
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags Biotech Chikungunya Health Care
From Benzinga
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
Tickers SAGE
Tags General News Market News
From Benzinga
Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion
Tickers MRNS MRUS
Tags Contracts News Long Ideas
From Benzinga
Outlook Therapeutics Stock Surges Positive ONS-5010 Data In Wet AMD Patients
Tickers OTLK RHHBY
Tags Biotech Penny Stocks General
From Benzinga
Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial
Tickers GLMD
Tags Penny Stocks Phase 3 Trial Briefs
From Benzinga
MediWound's NexoBrid Shows Significant Beneficial Impact On Pediatric Burn Patients
Tickers MDWD
Tags Briefs Biotech Health Care
From Benzinga
Kadmon's REZUROCK Scores Quick FDA Win For Chronic Graft-Versus-Host Disease
Tickers KDMN
Tags Phase 3 Trial Briefs KDMN
From Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
Tickers GILD
Tags HIV Biotech Health Care
From Benzinga
GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies
Tickers AZN FGEN GSK
Tags Phase 3 Trial GSK Briefs
From Benzinga
Alexion's Ultomiris Shows Compelling, Durable Efficacy In Rare Muscle Weakness Disorder
Tickers ALXN
Tags Benzinga General ALXN
From Benzinga
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
Tickers THTX
Tags General NASH Market News
From Benzinga
Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
Tickers EQ
Tags Briefs FDA Health Care
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today